Aalen, Germany

Georg Ankerhold

This inventor holds 1 USPTO granted patent. Top assignee: Dräger Medizintechnik Gmbh. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Georg Ankerhold. Retrieved from https://idiyas.com/inventor/georg-ankerhold-m7u0l0db

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Georg Ankerhold: Innovator in Lung Function Measurement

Introduction

Georg Ankerhold is a notable inventor based in Aalen, Germany. He has made significant contributions to the field of medical technology, particularly in the measurement of lung function. His innovative approach has led to advancements that can improve respiratory health assessments.

Latest Patents

Ankerhold holds a patent for a process designed to determine the functional residual capacity (FRC) of the lungs during respiration. This process utilizes an environmentally friendly trace gas, specifically fluoropropanes, to accurately measure the FRC. By analyzing the expiratory trace gas concentration and the expired breathing gas volume, values for the FRC can be calculated for individual breaths. This method enhances the precision of lung function assessments based on the convergence behavior of the measured values.

Career Highlights

Georg Ankerhold is associated with Dräger Medizintechnik GmbH, a company renowned for its medical technology innovations. His work at Dräger has positioned him as a key player in the development of advanced respiratory measurement techniques.

Collaborations

Ankerhold has collaborated with esteemed colleagues, including Jochim Koch and Dieter Weismann. Their combined expertise has contributed to the successful development of innovative solutions in the medical field.

Conclusion

Georg Ankerhold's contributions to lung function measurement exemplify the impact of innovation in medical technology. His patent for determining functional residual capacity showcases his commitment to improving respiratory health assessments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…